Inactivating Ptch mutations have been identified in various tumors including basal cell carcinoma, medulloblastoma and RMS [4–6] thus supporting a role for Ptch as a tumor suppressor gene. This evidence concerns the gene PTCH1 and basal cell carcinoma.